The US FDA is alerting combination product sponsors to gear up for the agency's intercenter consult request (ICCR) process, as all combination products will be included in the pilot upon its implementation by mid-2017.
A final process will be established and implemented across the agency by this point in time that will apply to all combination product submissions, FDA spokesman Michael Felberbaum told the Pink Sheet
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?